Tom Takach Named President of Sierra Pacific Windows
Jul 24, 2017 19:43 pm UTC| Business
RED BLUFF, Calif., July 24, 2017 -- Sierra Pacific Windows announces that Tom Takach has been named President. Takach will succeed Kendall Pierson, who is retiring after 33 years with Sierra Pacific Industries. ...
Jul 24, 2017 19:36 pm UTC| Business
NEW YORK, July 24, 2017 -- LedgerX, the New York-based institutional trading and clearing platform for digital currencies, receives approval to operate the first U.S. federally-regulated exchange and clearing house for...
L.B. Foster Company to Report Second Quarter 2017 Operating Results on August 3, 2017
Jul 24, 2017 19:23 pm UTC| Business
PITTSBURGH, July 24, 2017 -- L.B. Foster Company (NASDAQ:FSTR), today announced that it will release second quarter 2017 operating results after the market closes on Thursday, August 3, 2017. L.B. Foster will host a...
Micron Solutions, Inc. Appoints Rodd E. Friedman to its Board of Directors
Jul 24, 2017 19:03 pm UTC| Business
FITCHBURG, Mass., July 24, 2017 -- Micron Solutions, Inc. (NYSE MKT:MICR) (the “Company”), announced today the appointment of Mr. Rodd E. Friedman to its Board of Directors, effective July 21, 2017. Mr. Friedman will...
Jul 24, 2017 19:00 pm UTC| Business
NEWPORT NEWS, Va., July 24, 2017 -- Huntington Ingalls Industries (NYSE:HII) announced today that the Department of Energy’s National Nuclear Security Administration has issued a “notice to proceed” to Mission Support...
Jul 24, 2017 19:00 pm UTC| Business
Louisville, KY, July 24, 2017 -- Appriss Health, provider of the most comprehensive platform for substance use disorder in the U.S., today announced it has signed an agreement with Deaconess Health System, consisting...
GW Pharmaceuticals to Report Q3 Financial Results and Host Conference Call on 7 August, 2017
Jul 24, 2017 19:00 pm UTC| Business
LONDON, July 24, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...